These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 27261457)

  • 1. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
    Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
    PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
    Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
    Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.
    Sato K; Yamashita-Kanemaru Y; Abe F; Murata R; Nakamura-Shinya Y; Kanemaru K; Muratani M; Veillette A; Goto M; Ito M; Shibuya A; Shibuya K
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.
    Li Z; Lin F; Zhuo C; Deng G; Chen Z; Yin S; Gao Z; Piccioni M; Tsun A; Cai S; Zheng SG; Zhang Y; Li B
    J Biol Chem; 2014 Sep; 289(39):26872-26881. PubMed ID: 25096571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.
    Watford WT; Wang CC; Tsatsanis C; Mielke LA; Eliopoulos AG; Daskalakis C; Charles N; Odom S; Rivera J; O'Shea J; Tsichlis PN
    J Immunol; 2010 Jan; 184(1):105-13. PubMed ID: 19955521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.
    Watford WT; Hissong BD; Durant LR; Yamane H; Muul LM; Kanno Y; Tato CM; Ramos HL; Berger AE; Mielke L; Pesu M; Solomon B; Frucht DM; Paul WE; Sher A; Jankovic D; Tsichlis PN; O'Shea JJ
    J Exp Med; 2008 Nov; 205(12):2803-12. PubMed ID: 19001140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
    Shao TY; Hsu LH; Chien CH; Chiang BL
    Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3
    Chen X; Berin MC; Gillespie VL; Sampson HA; Dunkin D
    Front Immunol; 2021; 12():637630. PubMed ID: 33717186
    [No Abstract]   [Full Text] [Related]  

  • 10. Attenuation of canonical NF-κB signaling maintains function and stability of human Treg.
    Ziegler LS; Gerner MC; Schmidt RLJ; Trapin D; Steinberger P; Pickl WF; Sillaber C; Egger G; Schwarzinger I; Schmetterer KG
    FEBS J; 2021 Jan; 288(2):640-662. PubMed ID: 32386462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of MEK1 promotes Treg cell instability in vivo.
    Guo J; Zhang J; Zhang X; Zhang Z; Wei X; Zhou X
    J Biol Chem; 2014 Dec; 289(51):35139-48. PubMed ID: 25361764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
    Chowdhury FZ; Estrada LD; Murray S; Forman J; Farrar JD
    PLoS One; 2014; 9(3):e92187. PubMed ID: 24642963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function.
    Huang W; Jeong AR; Kannan AK; Huang L; August A
    J Immunol; 2014 Sep; 193(5):2267-72. PubMed ID: 25063868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.
    Dominitzki S; Fantini MC; Neufert C; Nikolaev A; Galle PR; Scheller J; Monteleone G; Rose-John S; Neurath MF; Becker C
    J Immunol; 2007 Aug; 179(4):2041-5. PubMed ID: 17675459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Gonadotropin-releasing Hormone Receptor Impedes the Immunosuppressive Activity of Decidual Regulatory T Cells via Deactivating the Mechanistic Target of Rapamycin Signaling.
    Wang X; Zhong L; Liu Q; Cai P; Zhang P; Lu Z; Li X; Liu J
    Immunol Invest; 2022 Jul; 51(5):1330-1346. PubMed ID: 34132158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinase ITK controls a Ca
    Anannya O; Huang W; August A
    Sci Signal; 2024 Jul; 17(846):eadh2381. PubMed ID: 39042726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
    Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
    J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells.
    Huijts CM; Schneiders FL; Garcia-Vallejo JJ; Verheul HM; de Gruijl TD; van der Vliet HJ
    J Immunol; 2015 Sep; 195(5):2038-45. PubMed ID: 26238486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of novel CD8
    Fan JN; Ho H; Chiang BL
    Cell Mol Life Sci; 2024 Aug; 81(1):327. PubMed ID: 39085655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.